bioAffinity Technologies closes $1.8 million registered direct offering
PositiveFinancial Markets

bioAffinity Technologies has successfully closed a $1.8 million registered direct offering, marking a significant milestone for the company. This funding will support their ongoing projects and innovations in the biotech sector, which is crucial for advancing healthcare solutions. Investors are optimistic about the potential growth and impact of bioAffinity's work, making this a noteworthy development in the industry.
— Curated by the World Pulse Now AI Editorial System